Tsalikian, Eva

An anti-CD3 antibody, teplizumab, in relatives at risk for type 1 diabetes

Herold, K. C., Bundy, B. N., Long, S. A., Bluestone, J. A., DiMeglio, L. A., Dufort, M. J., Gitelman, S. E., Gottlieb, P. A., Krischer, J. P., Linsley, P. S., et al. (2019) · New England Journal of Medicine

Diabetes and associated disordersT-cell and B-cell Immunology

Cited by 1,189

Teplizumab improves and stabilizes beta cell function in antibody-positive high-risk individuals

Sims, E. K., Bundy, B. N., Stier, K., Serti, E., Lim, N., Long, S. A., Geyer, S. M., Moran, A., Greenbaum, C. J., Evans-Molina, C., et al. (2021) · Science Translational Medicine

Diabetes and associated disordersT-cell and B-cell Immunology

Cited by 377

Effects of physiologic levels of glucagon and growth hormone on human carbohydrate and lipid metabolism. Studies involving administration of exogenous hormone during suppression of endogenous hormone secretion with somatostatin

Gerich, J. E., Lorenzi, M., Bier, D. M., Tsalikian, E., Schneider, V, Karam, J. H., & Forsham, P. H. (1976) · Journal of Clinical Investigation

Growth Hormone and Insulin-like Growth FactorsPancreatic function and diabetes

Cited by 198

Studies on the Mechanism of Epinephrine-induced Hyperglycemia in Man: Evidence for Participation of Pancreatic Glucagon Secretion

Gerich, J. E., Lorenzi, M., Tsalikian, E., & Karam, J. H. (1976) · Diabetes

Pancreatic function and diabetesDiabetes Management and Research

Cited by 118

Defective glucose counterregulation after subcutaneous insulin in noninsulin-dependent diabetes mellitus. Paradoxical suppression of glucose utilization and lack of compensatory increase in glucose production, roles of insulin resistance, abnormal neuroendocrine responses, and islet paracrine interactions.

Bolli, G. B., Tsalikian, E., Haymond, M. W., Cryer, P. E., & Gerich, J. E. (1984) · Journal of Clinical Investigation

Pancreatic function and diabetesDiabetes Management and Research

Cited by 108

Metformin Improves Peripheral Insulin Sensitivity in Youth With Type 1 Diabetes

Cree-Green, M., Bergman, B. C., Cengiz, E., Fox, L. A., Hannon, T. S., Miller, K., Nathan, B., Pyle, L., Kahn, D., Tansey, M., et al. (2019) · The Journal of Clinical Endocrinology & Metabolism

Diabetes Management and ResearchDiabetes Treatment and Management

Cited by 101

Feasibility of prolonged continuous glucose monitoring in toddlers with type 1 diabetes: CGM and very young children with T1D

Tsalikian, E., Fox, L., Weinzimer, S., Buckingham, B., White, N. H., Beck, R., Kollman, C., Xing, D., Ruedy, K., & Diabetes Research in Children Network (DirecNet) Study Group (2012) · Pediatric Diabetes

Diabetes Management and ResearchDiabetes and associated disorders

Cited by 83

A Practical Approach to Using Trend Arrows on the Dexcom G5 CGM System to Manage Children and Adolescents With Diabetes

Laffel, L. M., Aleppo, G., Buckingham, B. A., Forlenza, G. P., Rasbach, L. E., Tsalikian, E., Weinzimer, S. A., & Harris, D. R. (2017) · Journal of the Endocrine Society

Diabetes Management and ResearchDiabetes Management and Education

Cited by 79

Stressors in Teens with Type 1 Diabetes and Their Parents: Immediate and Long-Term Implications for Transition to Self-Management

Ersig, A. L., Tsalikian, E., Coffey, J., & Williams, J. K. (2016) · Journal of Pediatric Nursing

Adolescent and Pediatric HealthcareDiabetes Management and Education

Cited by 64